{"filing":{"accession_number":"0001193125-26-259481","cik":"0001426800","ticker":"ASMB","company_name":"ASSEMBLY BIOSCIENCES, INC.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"asmb-20260604.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1426800/000119312526259481/asmb-20260604.htm"},"events":[{"id":3721,"run_id":3263,"accession_number":"0001193125-26-259481","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Assembly Biosciences held its Annual Meeting of Stockholders on June 4, 2026, with shareholders voting on five proposals: election of nine directors, advisory vote on named executive officer compensation, ratification of Ernst \u0026 Young LLP as auditor, and approval of amendments to the 2018 Stock Incentive Plan and ESPP to increase reserved shares.","company_name":"ASSEMBLY BIOSCIENCES, INC.","ticker":"ASMB","filing_date":"2026-06-05","items":[{"id":4728,"accession_number":"0001193125-26-259481","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports stockholder approval of Amendment No. 3 to the 2018 Stock Incentive Plan, increasing reserved shares from 1,478,333 to 2,678,333, and Amendment No. 2 to the ESPP, increasing reserved shares from 225,000 to 515,000. These amendments directly expand the pool of equity available for compensatory arrangements to directors, officers, and employees, which is a material modification to compensation plans requiring 8-K disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:01:10.735802+00:00","company_name":"","ticker":null,"filing_date":""},{"id":4729,"accession_number":"0001193125-26-259481","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Assembly Biosciences' Annual Meeting held on June 4, 2026, covering five proposals: election of nine directors, advisory vote on named executive officer compensation, ratification of Ernst \u0026 Young LLP as auditor, approval of equity plan amendments (2018 Plan and ESPP), and detailed voting tallies for each. The filing directly matches Item 5.07 requirements and is material to investors as it documents governance outcomes and shareholder approval of equity incentive programs.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:01:10.735802+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4728,"accession_number":"0001193125-26-259481","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports stockholder approval of Amendment No. 3 to the 2018 Stock Incentive Plan, increasing reserved shares from 1,478,333 to 2,678,333, and Amendment No. 2 to the ESPP, increasing reserved shares from 225,000 to 515,000. These amendments directly expand the pool of equity available for compensatory arrangements to directors, officers, and employees, which is a material modification to compensation plans requiring 8-K disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:01:10.735802+00:00","company_name":"ASSEMBLY BIOSCIENCES, INC.","ticker":"ASMB","filing_date":"2026-06-05"},{"id":4729,"accession_number":"0001193125-26-259481","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Assembly Biosciences' Annual Meeting held on June 4, 2026, covering five proposals: election of nine directors, advisory vote on named executive officer compensation, ratification of Ernst \u0026 Young LLP as auditor, approval of equity plan amendments (2018 Plan and ESPP), and detailed voting tallies for each. The filing directly matches Item 5.07 requirements and is material to investors as it documents governance outcomes and shareholder approval of equity incentive programs.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:01:10.735802+00:00","company_name":"ASSEMBLY BIOSCIENCES, INC.","ticker":"ASMB","filing_date":"2026-06-05"}]}